European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-06-18

Cell and gene therapy based approaches for treatment of Parkinson's disease: from models to clinics

Objetivo

Parkinson s disease is one of the common causes of disability in the aging population, representing a major health problem for the affected individuals and a socioeconomic burden to the society. In the present proposal, the applicant puts forward an ambitious but feasible program to tackle a number of significant issues that remain unsolved in the field. He combines his strong track record in animal models of Parkinson s disease and novel cell and gene therapy-based therapeutic strategies with powerful bio-imaging techniques in order to make bold steps towards translation of new and better treatments to patients suffering from this illness. He does so in a manner that combines, on one hand, the strength of clearly-defined hypotheses and well-established tools for results towards clinical translation, with high-risk high-reward projects that hold the potential to yield ground-breaking discoveries in implementation of novel imaging techniques, on the other.

Convocatoria de propuestas

ERC-2009-StG
Consulte otros proyectos de esta convocatoria

Régimen de financiación

ERC-SG - ERC Starting Grant

Institución de acogida

MAX IV Laboratory, Lund University
Aportación de la UE
€ 1 508 940,00
Dirección
Paradisgatan 5c
22100 LUND
Suecia

Ver en el mapa

Región
Södra Sverige Sydsverige Skåne län
Tipo de actividad
Higher or Secondary Education Establishments
Investigador principal
Deniz Kirik (Prof.)
Contacto administrativo
Deniz Kirik (Prof.)
Enlaces
Coste total
Sin datos

Beneficiarios (1)